pubrio
Duke-NUS Medical School logo

Duke-NUS Medical School

Educational
+2
duke-nus.edu.sg
Higher Education1,500+ employeesFounded 2005🇸🇬 Singapore

Duke-NUS is Singapore’s flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted ‘Clinicians Plus’ poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five signature research programmes and 10 centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore’s largest healthcare group. This strategic alliance has spawned 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives. For more information, please visit www.duke-nus.edu.sg

Founded
2005
Employees
1,500+
Industry
Higher Education
Company type
Educational
Headquarters
🇸🇬Singapore, Singapore (+1)
Specialties
EducationHigher EducationResearchHealthcare
3 / 4
Active markets
Indonesia · Australia · Canada
2
New markets
Canada · Philippines
Low
Confidence
mostly early signals
-100%
Momentum
vs prior period
14 / 100
Expansion Score
Early
Stages3Exploring1Investing
3 signals · Last 90 days

Global expansion

Live
IndonesiaAustraliaCanada
Stages
ExploringInvestingLandingOperating
+1more marketsLocked
3 of 4 shown

Unlock the market timeline & signal feed

Activity pulse

3 signals in the last 90 days.

Last 90 days
Hiring
0
No activity
Marketing & PR
0
No activity
Product & Tech
0
No activity
+2more categoriesLocked
3 of 5 shown

Market entry timeline

The order this company entered each market — oldest to newest

1
🇦🇺Australia1st market entered · 2025Advancing
Investing
1 signalInvesting stage
2
🇮🇩Indonesia2nd market entered · 2025Advancing
Exploring
3 signalsExploring stage
3
🇨🇦Canada3rd market entered · 2026Advancing
Exploring
1 signalExploring stage
+1more marketsLocked
3 of 4 shown
Current stageInvestingCommitting resources
Confidence38%Low
Tracking since2025first signal

Recent signals

Partnership🇮🇩 Indonesia2mo ago

Feihe leads global collaboration in neuroscience research

Partnership🇵🇭 Philippines2mo ago

Feihe leads global collaboration in neuroscience research

Sign up to see the full signal feed

Good to know

Frequently Asked Questions Regarding Duke-NUS Medical School

Quick answers about Duke-NUS Medical School's business, markets, and growth signals.

Duke-NUS is Singapore’s flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted ‘Clinicians Plus’ poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five signature research programmes and 10 centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore’s largest healthcare group. This strategic alliance has spawned 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives. For more information, please visit www.duke-nus.edu.sg

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

© 2026 Pubrio. All rights reserved.